(en) A. Sánchez-Danés, J. C. Larsimont, M. Liagre, E. Muñoz-Couselo, G. Lapouge et al., « A slow-cycling LGR5 tumour population mediates basal cell carcinoma relapse after therapy », Nature, vol. 562, no 7727, , p. 434-438 (DOI10.1038/s41586-018-0603-3).
(en) Julia Maria Ressler, Maud Plaschka, Rita Silmbrod et Victoria Bachmayr, « Efficacy and tolerability of neoadjuvant therapy with Talimogene laherparepvec in cutaneous basal cell carcinoma: a phase II trial (NeoBCC trial) », Nature Cancer, vol. 6, no 1, , p. 51–66 (ISSN2662-1347, DOI10.1038/s43018-024-00879-x, lire en ligne, consulté le )
(en) Julia Maria Ressler, Maud Plaschka, Rita Silmbrod et Victoria Bachmayr, « Efficacy and tolerability of neoadjuvant therapy with Talimogene laherparepvec in cutaneous basal cell carcinoma: a phase II trial (NeoBCC trial) », Nature Cancer, vol. 6, no 1, , p. 51–66 (ISSN2662-1347, DOI10.1038/s43018-024-00879-x, lire en ligne, consulté le )
nature.com
(en) Julia Maria Ressler, Maud Plaschka, Rita Silmbrod et Victoria Bachmayr, « Efficacy and tolerability of neoadjuvant therapy with Talimogene laherparepvec in cutaneous basal cell carcinoma: a phase II trial (NeoBCC trial) », Nature Cancer, vol. 6, no 1, , p. 51–66 (ISSN2662-1347, DOI10.1038/s43018-024-00879-x, lire en ligne, consulté le )